Jpmorgan Chase & CO Novo Nordisk A S Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,409,228 shares of NVO stock, worth $438 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,409,228
Previous 4,936,869 9.57%
Holding current value
$438 Million
Previous $705 Million 8.6%
% of portfolio
0.05%
Previous 0.06%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$119.07 - $145.42 $56.2 Million - $68.7 Million
472,359 Added 9.57%
5,409,228 $644 Million
Q3 2024

Nov 08, 2024
BUY
$119.07 - $145.42 $56.2 Million - $68.7 Million
472,359 Added 9.57%
5,409,228 $644 Million
Q2 2024

Dec 26, 2024
SELL
$122.71 - $146.91 $58 Million - $69.4 Million
-472,359 Reduced 8.73%
4,936,869 $705 Million
Q2 2024

Aug 12, 2024
SELL
$122.71 - $146.91 $83.8 Million - $100 Million
-682,706 Reduced 12.15%
4,936,869 $705 Million
Q1 2024

Dec 26, 2024
BUY
$102.11 - $135.92 $21.5 Million - $28.6 Million
210,347 Added 3.89%
5,619,575 $722 Million
Q1 2024

May 10, 2024
BUY
$102.11 - $135.92 $89.6 Million - $119 Million
877,751 Added 18.51%
5,619,575 $722 Million
Q4 2023

Dec 26, 2024
SELL
$87.78 - $105.45 $58.6 Million - $70.4 Million
-667,404 Reduced 12.34%
4,741,824 $491 Million
Q4 2023

Feb 12, 2024
BUY
$87.78 - $105.45 $235 Million - $282 Million
2,678,732 Added 129.84%
4,741,824 $491 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $103 Million - $226 Million
1,130,687 Added 121.27%
2,063,092 $188 Million
Q2 2023

Aug 11, 2023
BUY
$155.98 - $172.65 $2.36 Million - $2.62 Million
15,150 Added 1.65%
932,405 $151 Million
Q1 2023

May 11, 2023
SELL
$132.34 - $159.14 $10.7 Million - $12.8 Million
-80,485 Reduced 8.07%
917,255 $146 Million
Q4 2022

Feb 13, 2023
SELL
$102.55 - $135.33 $12.5 Million - $16.5 Million
-121,720 Reduced 10.87%
997,740 $135 Million
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $94,327 - $115,760
990 Added 0.09%
1,119,460 $112 Million
Q2 2022

Aug 11, 2022
BUY
$103.24 - $121.81 $34.4 Million - $40.6 Million
333,259 Added 42.44%
1,118,470 $125 Million
Q1 2022

May 11, 2022
BUY
$93.1 - $112.54 $34.4 Million - $41.6 Million
369,791 Added 89.02%
785,211 $87.2 Million
Q4 2021

Feb 10, 2022
BUY
$95.88 - $117.08 $4.88 Million - $5.96 Million
50,898 Added 13.96%
415,420 $46.5 Million
Q3 2021

Nov 12, 2021
BUY
$84.42 - $106.62 $30.8 Million - $38.9 Million
364,522 New
364,522 $35 Million

Others Institutions Holding NVO

# of Institutions
1,918
Shares Held
318M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $183B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email